REGISTERED NUMBER: 08651822 (England and Wales)

Unaudited Financial Statements

for the Year Ended 28 February 2025

for

HC PHARMA LIMITED

Page

Balance Sheet

1

FIXED ASSETS

913,518

801,647

CURRENT ASSETS

341,283

327,341

CREDITORS

Amounts falling due within one year

(194,995

)

(190,428

)

NET CURRENT ASSETS

146,288

136,913

TOTAL ASSETS LESS CURRENT LIABILITIES

1,059,806

938,560

CREDITORS

Amounts falling due after more than one year

(661,731

)

(517,418

)

NET ASSETS

398,075

421,142

CAPITAL AND RESERVES

398,075

421,142

NOTES TO THE FINANCIAL STATEMENTS

1.	AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the year was 9 (2024 - 8 ) .

2.	DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 28 February 2025 and 29 February 2024:

2025

2024

£

£

Hinesh Chauhan

Balance outstanding at start of year

(3,697

)

13,788

Amounts advanced

29,620

49,132

Amounts repaid

(25,100

)

(66,617

)

Amounts written off

-

-

Amounts waived

-

-

Balance outstanding at end of year

823

(3,697

)

Dividends issued to the director during the year = Nil (£29,000 in 2024)

Dividends issued to the holding company during the year = £100,000 ( £50,000 in 2024)

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 28 February 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 28 February 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the director and authorised for issue on 18 November 2025 and were signed by:

Hinesh Chauhan - Director